Atherosclerosis manifests as plaque build-up in arteries, and its multifactorial etiology has been shown to involve the activities of inflammatory cells, vascular smooth muscle cells (VSMCs), and intracellular and extracellular lipids [1] [2] [3] [4] .
interleukin 6 (IL-6), transforming growth factor beta 1 (TGF-β1), tumor necrosis factor alpha (TNF-α), thrombin, fibroblast growth factor (FGF), insulin-like growth factor 1 (IGF-1), platelet-derived growth factor (PDGF), urokinase plasminogen activator, angiotensin II, and vascular endothelial growth factor (VEGF), which are all expressionally upregulated in atherosclerotic lesions [9] [10] [11] [12] . In the diseased state, VSMCs re-enter the cell cycle, proliferate, and migrate from tunica media to intima [13] . Furthermore, after vessel injury, intimal VSMCs adopt a synthetic phenotype, characterized by hyperplasia or hypertrophy and matrix protein accumulation in intima and/or media with or without lipid deposition, which in total, result in arterial wall thickening and stiffness [14, 15] . The abnormal proliferation and migration of VSMCs in arterial walls are important factors in the development of atherosclerosis [15] . In particular, VSMC apoptosis has been proposed to play a significant role in the control of the thickening of intima and/or media [16] .
Gambogic acid (GA), the main active ingredient of Gamboge hanburyi, is a representative oriental medicine, which has been used for its detoxifying, homeostatic, and anti-inflammatory properties for thousands of years [17] . Furthermore, the anticancer effect of GA has been attributed to its activation of impaired apoptosis pathways in cancerous cells via the down-regulation of telomerase [17] . Recent reports have shown that the molecular mechanism underlying the apoptotic effect of GA involves its interaction with transferrin receptor [18] and the subsequent suppression of the nuclear factor-kB signaling pathway [19] . Simvastatin is a cholesterol-lowering agent that is widely used for the treatment and prevention of atherosclerosis [20] . Furthermore, simvastatin has been reported to lower nitric oxide (NO) synthase expression and induce cell cycle arrest and apoptosis [21] . These observations suggest the actions of GA and simvastatin are related directly or indirectly with apoptosis. In addition, in a previous study, we found that SMCs were easily isolated using simple enzymatic method from the rat aortic wall at purities of ~90% [22] .
In this study, we investigated whether GA has apoptotic effects on aortic SMCs, and subsequently, we compared its apoptotic effects with those of simvastatin. To examine the apoptotic effects of the two drugs, SMCs were isolated from Sprague-Dawley rats. Cell purities were determined by immunofluorescent (IF) staining using α-smooth muscle actin (α-SMA) antibody, and the IC 50 values of GA and simvastatin with respect to cell death were determined using a MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The apoptotic effects of both drugs were examined by treating SMCs at half maximal inhibitory concentration (IC 50 ) levels and then analyzing live cell images and fluorescein isothiocyanate (FITC) annexin-V and propidium iodide (PI) double staining results. Levels of apoptosis-regulating proteins were determined by western blotting.
Materials and Methods

Reagents
Sprague-Dawley rats (4-6 week) were obtained from Samtaco Bio (Osan, Korea). Dulbecco's modified Eagle's medium (DMEM), 1×non-essential amino acids, 1×sodi-um pyruvate, N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES), penicillin, streptomycin, trypsin-Ethylenediaminetetraacetic acid (EDTA), and fetal bovine serum (FBS) were purchased from Gibco (Grand Island, NY, USA). GA, simvastatin, MTT, heparin sodium salt, gelatin, dimethyl sulfoxide (DMSO), PI and 4′,6-diamidino-2-phenylindole (DAPI) were from Sigma-Aldrich (Saint Louis, MO, USA). Normal goat serum (10%), rat anti-rabbit α-SMA, and FITC-conjugated goat anti-rat Immunoglobulin G (IgG) were from Zymed (Carlsbad, CA, USA). Fluorescent mounting medium was purchased from Dako Cytomation (UK), FITC annexin-V antibody from Abcam (UK), and BCA protein assay kits from Pierce (Los Angeles, CA, USA). Immobilon-P membranes and enhanced chemiluminescence (ECL) western blotting kits were obtained from Millipore (Hertfordshire, UK). Rabbit poly ADP-ribose polymerase (PARP) polyclonal antibodies were purchased from Cell signaling Technology (Boston, MA, USA). Rabbit procaspase-3 polyclonal antibodies were from Enzo Life Sciences (Farmingdale, NY, USA). Rabbit myeloid cell leukemia sequence 1 (Mcl-1) polyclonal antibody and rabbit β-Actin polyclonal antibody were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Benzyloxycarbonyl-Val-Ala-Asp (OMe)-fluoromethylketone (z-VAD-fmk) were from Calbiochem (San Diego, CA, USA).
Isolation of aortic SMCs
Aortic SMCs were isolated as we previously described 
Maintenance of SMCs
Plated cells were maintained in DMEM supplemented with 20% FBS, L-glutamine, non-essential amino acids, sodium pyruvate, heparin sodium salt, HEPES, penicillin (100 U/mL), and streptomycin (100 mg/mL) in a humidified 95% air/5% CO 2 incubator. These cells were grown in 100Φ plates, and then subcultured for no more than 5 passages. Cells were stored in nitrogen at -196� C, and used for experiments after thawing.
IF staining against α α-SMA
IF staining was performed as previously described [23] . Briefly, subcultured cells were seeded at 1×10 4 cells/cm 2 on cover glasses, and then fixed in 3.7% paraformaldehyde solution. Rat anti-rabbit α-SMA and FITC-conjugated goat anti-rat IgG antibodies were diluted at 1 : 100 and 1 : 100, respectively. Cytoplasmic α-SMA expression was used to identify SMCs. Nuclei were counter-stained with DAPI. Cells were photomicrographed under a Leica DM 6000B fluorescent microscope (Wetzlar, Germany). Experiments were performed three times (n= =3).
MTT assay and the IC 50 values of GA and simvastatin
Cell viabilities were evaluated using a MTT assay, as previously described [24] . MTT solution was prepared at 5 mg/mL in PBS and filtered through a 0.2 μm filter immediately before use. To measure cell viabilities, subcultured cells were seeded into 24-well plates at 5×10 4 cells per well and treated with 0, 0.2, 0.5, 1, or 5 μM of GA or 0, 1, 5, 30, or 60 μM of simvastatin for 24 h. Briefly, 100 μL (5 mg/mL) of MTT working solution were added to each well. Formazan crystals were dissolved in 100 μL of DMSO, and well absorbances were measured at 570 nm using an ELISA Microplate Reader (BIO-TEK, Norcross, GA, USA).
Results are expressed as relative viabilities (%) versus nontreated controls. Cells numbers in each well were counted, and experiments were performed three times (n= =3).
Live cell imaging
Subcultured cells were seeded at 1×10 4 cells per well into 96 well plates before being treated with 1 μM GA or 30 μM simvastatin. Live cell images after 24 h of treatment were acquired using Leica DMIRE2 inverted microscope (Wetzlar, Germany).
FITC annexin-V and PI double-staining
Cellular DNA contents were assessed by flow cytometry. Subcultured cells were plated at 1×10 4 cells/cm 2 in 100Φ
plates and treated with 1 μM GA or 30 μM simvastatin. Attached cells were collected using trypsin and 2.2 mmol/ L EDTA in PBS, mixed with the detached cells present in supernatants, and centrifuged. Cells were then rinsed with PBS, suspended in a solution containing 1.5 mg/L FITC annexin-V and 1.8 mmol/L CaCl 2 for 1 h at 37� C, washed twice with PBS, and resuspended in a solution containing FITC annexin-V antibody for 30 min at 37� C. Cells were then suspended in a solution containing 75 mmol/L PI, and analyzed using a FACScanner (Becton Dickinson, Franklin Lake, NJ, USA) and Cell Quest software. More than 10,000 cells were analyzed per sample. Experiments were performed three times (n= =3).
Western blot
Subcultured cells were plated at 1×10 4 cells/cm 2 in 100Φ plates, and treated with 1 μM GA or 30 μM simvastatin for 24 h. Cell lysates were prepared by suspending 5 ×10 6 cells in 100 μL of lysis buffer (137 mM NaCl, 15 mM ethylene glycol tetraacetic acid (EGTA), 0.1 mM sodium orthovanadate, 15 mM MgCl 2 , 0.1% Triton X-100, 25 mM 3-(N-morpholino)propanesulfonic acid (Mops), 100 μM phenylmethylsulfonyl fluoride, and 20 μM leupeptin, adjusted to pH 7.2. Cells were then disrupted by sonication and extracted at 4� C for 30 min. The proteins (50 μg) obtained were electro-transferred to Immobilon-P membranes. PARP (1 : 1000), procaspase-3 (1 : 3000), and Mcl-1 (1 : 1000) were detected using an ECL western blotting kit (Millipore). β-Actin was used as loading control using β-Actin antibody at a dilution of 1 : 2000, and experiments were performed three times (n= =3). 
FACS
Statistical analysis
Data are presented as means±SDs. SPSS ver. 13.0 statistical software (SPSS, Inc., Chicago, IL, USA) was used for the analysis. Paired comparisons were performed using the Student's t-test. Statistical significance was accepted for p values ⁄0.05.
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Results
Identification of aortic SMCs using α α-SMA
The purities of subcultured cells were determined by calculating percentages of α-SMA positive cells among cells grown on cover glasses. α-SMA positive cells, that is, aortic SMCs, had green cytoplasm after IF staining, whereas fibroblast cytoplasm was not stained (Fig. 1A, C) . SMC and fibroblast nuclei were counter-stained blue using DAPI (Fig. 1B) . Of the subcultured cells, 92.3±4.11% (n= =3) stained positively for α-SMA (Fig. 1C) .
Cells viabilities after GA or simvastatin treatment
To determine the IC 50 values of GA and simvastatin, SMCs were assayed by MTT and percentage viabilities were determined at various concentrations (0.2-60 μM) after exposure for 24 h. As shown in 
Live cell images
Live non-treated controls were flatter (Fig. 3A , B, C, E) than cells treated with 1 μM GA (Fig. 3D) or 30 μM simvastatin (Fig. 3F ) for 24 h. In addition, some treated cells detached from plate wells, and produced empty spaces.
Analysis of apoptosis by FITC annexin-V and PI double-staining
To test the hypothesis that GA increases cell death by inducing apoptosis, we used an Annexin-V-FITC and PI double staining technique. As shown in Fig. 4B . GA (1 μM)-treated aortic SMCs showed higher percentages of apoptotic cells than 30 μM simvastatin-treated SMCs (26.4± 2.37% vs. 8.3±1.54%, respectively; Fig. 4B, C; P⁄0 .05, n= =3), whereas simvastatin-treated SMCs resulted in higher percentages of necrotic cells than GA-treated SMCs (43.2±2.76% vs. 24.9±3.12%, respectively; Fig. 4B, C ; P⁄0.05, n= =3).
Levels of apoptosis regulating proteins
Cells undergoing apoptosis execute the death program by activating caspases, which then cleave PARP and procaspase-3. Accordingly, we analyzed the expression levels of PARP and procaspase-3 and levels of the cleavage products of PARP and procaspase-3. As demonstrated in Fig.   5 , exposure to GA (1 μM) led to reductions in the 116 KDa precursor of PARP and 32 KDa precursor of procaspase-3, and to the concomitant cleavages of PARP and procaspase-3. To investigate the mechanism responsible for GAinduced apoptosis, we analyzed changes in Mcl-1 protein levels. Mcl-1 protein expression was decreased when SMCs were treated with GA at 1 μM. In contrast, Mcl-1 protein levels remained constant after treating cells with 30 μM simvastatin (Fig. 5 ).
z-VAD pretreatment
We next examined whether activation of the caspase pathway plays a critical role in 1 μM GA-induced apoptosis. As shown in Fig. 6A , GA-induced apoptosis was completely prevented by pre-treatment with z-VAD-fmk (a potent general caspase inhibitor), as determined by FACS (P⁄0.05, n= =3). Furthermore, z-VAD-fmk prevented all caspase-related events, such as, the cleavages of PARP and procaspase-3 (Fig. 6B) . Furthermore, pretreatment with z-VAD-fmk prevented Mcl-1 protein down-regulation by GA.
Discussion
In a preliminary study, we developed a means of harvesting aortic SMCs at relatively high purity to investigate the roles played by VSMCs during the pathogenesis of atherosclerosis [22] . In the present study, we investigated whether GA induces the apoptosis of aortic SMCs isolated from rat aortas using a simple enzymatic method [22] , and compared the apoptotic potencies of GA and simvastatin.
In the present study, GA was administered to SMCs at 1 μM (its IC 50 ) level as determined using the MTT assay, whereas simvastatin, which is commonly used to treat atherosclerosis, was used at its IC 50 (30 μM). These IC 50 values suggest that GA is considerably more potent than simvastatin based on SMC viability, which is not surprising because simvastatin is a cholesterol-lowering agent [20] .
In the present study, live images of aortic SMCs treated with GA (1 μM) or simvastatin (30 μM) revealed a rounder morphology and some cells detached from culture vessels. These microscopic findings suggest that both drugs have cytotoxic effects on SMCs, and this is supported by our observations of their apoptotic/necrotic effects by FITC annexin-V and PI double staining.
GA at 1 μM resulted in more SMC apoptosis than simvastatin at 30 μM (P⁄0.05, n= =3), whereas simvastatin produced more necrotic cells (P⁄0.05, n= =3). The anticancer effect of GA has been largely attributed to its activation of impaired apoptosis pathways in cancerous cells via the down-regulation of telomerase [17] . Apoptosis is essential for arterial remodeling [24] , and thus, our results suggest that 1 μM GA is a more potent apoptotic agent for the control of aortic SMC proliferation in atherosclerosis. In fact, GA at 1 μM produced similar levels (~25%, n= =3) of apoptotic and necrotic cells, which in turn, suggests that the maximum apoptotic effect of GA might be obtained at a concentration lower than 1 μM in vitro.
In the present study, 1 μM GA induced the cleavages of PARP and procaspase-3, whereas 30 μM simvastatin did not, which suggests that the cleavages of PARP and procaspase-3 are associated with caspase activation. Furthermore, pretreatment with z-VAD-fmk attenuated GA-induced apoptosis. Thus, these results indicate that GA-induced apoptosis was mediated via a caspase-dependent pathway, which is in accord with a recent reported that the cytotoxic effect of GA on neuroblastoma cells is mediated by a caspase-dependent signaling pathway [25] . In addition, pretreatment with z-VAD-fmk prevented Mcl-1 protein downregulation by 1 μM GA, indicating that the downregulation of Mcl-1 protein was caused by caspase activation. Inhibition of GA-induced Mcl-1 protein downregulation by z-VAD-fmk is strongly supported by a report that Mcl-1 protein can be cleaved by activated caspase 3 [26] . The apoptotic effect of simvastatin in atherosclerosis is also known to involve down-regulation of p53 and the up-regulations of Bcl-2 and Bcl-xL [27] . Taken together, our in vitro results on rat aortic SMCs suggest that GA might be more effective than simvastatin at inducing apoptosis, which suggests that GA is a promising therapeutic proposition for the treatment of atherosclerosis. We suggest that further studies be conducted to examine the effects of GA in a disease model of atherosclerosis.
